Here’s What Hedge Funds Think About Colgate-Palmolive Company (CL)

Is Colgate-Palmolive Company (NYSE:CL) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise to work. The top picks of these firms have historically outperformed the market when we account for known risk factors, making them very valuable investment ideas.

Is Colgate-Palmolive Company (NYSE:CL) worth your attention right now? Money managers are taking a pessimistic view. The number of long hedge fund bets retreated by 3 lately. Our calculations also showed that cl isn't among the 30 most popular stocks among hedge funds. CL was in 42 hedge funds' portfolios at the end of March. There were 45 hedge funds in our database with CL holdings at the end of the previous quarter.

So, why do we pay attention to hedge fund sentiment before making any investment decisions? Our research has shown that hedge funds' small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the market by 40 percentage points since May 2014 through May 30, 2019 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter. Even if you aren't comfortable with shorting stocks, you should at least avoid initiating long positions in our short portfolio.

Let's view the new hedge fund action encompassing Colgate-Palmolive Company (NYSE:CL).

What have hedge funds been doing with Colgate-Palmolive Company (NYSE:CL)?

At Q1's end, a total of 42 of the hedge funds tracked by Insider Monkey were long this stock, a change of -7% from the fourth quarter of 2018. By comparison, 36 hedge funds held shares or bullish call options in CL a year ago. So, let's see which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

Among these funds, D E Shaw held the most valuable stake in Colgate-Palmolive Company (NYSE:CL), which was worth $539.9 million at the end of the first quarter. On the second spot was Renaissance Technologies which amassed $360 million worth of shares. Moreover, Two Sigma Advisors, AQR Capital Management, and Alkeon Capital Management were also bullish on Colgate-Palmolive Company (NYSE:CL), allocating a large percentage of their portfolios to this stock.

Seeing as Colgate-Palmolive Company (NYSE:CL) has faced declining sentiment from the entirety of the hedge funds we track, it's easy to see that there lies a certain "tier" of hedge funds that elected to cut their positions entirely heading into Q3. Interestingly, Alex Snow's Lansdowne Partners sold off the largest stake of the 700 funds watched by Insider Monkey, valued at an estimated $238.3 million in stock, and Steve Cohen's Point72 Asset Management was right behind this move, as the fund cut about $76.4 million worth. These moves are intriguing to say the least, as aggregate hedge fund interest dropped by 3 funds heading into Q3.